Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House-passed opioid abatement bill (H 218) draws committee scrutiny over appropriations and governance
Summary
Senate Health & Welfare reviewed H 218, the house-passed opioid abatement appropriation bill, including roughly $9.8–$9.9 million in FY26 awards and changes to advisory-committee governance and statutory terminology.
Senate Health & Welfare members examined H 218, the house-passed bill that centralizes opioid abatement appropriations into a single bill and adds policy changes for how the special fund is governed and monitored.
Teresa Wood, chair of House Human Services and a presenter on the bill, told the committee that Human Services worked to align the recommendations of the opioid abatement advisory committee and the Department of Health: “House Human Services really took great pains ... to avoid deviating from the recommendations of the opioid advisory settlement committee.” The administration asked that the special-fund appropriations be consolidated into a single bill for clarity.
Nolan (fiscal office) walked the committee through the fiscal note: the house version of H 218 appropriates roughly $9.8–$9.9 million for fiscal year 2026, and includes several line items…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat

